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Structure of the Complete Extracellular Domain of the
Common b Subunit of the Human GM-CSF, IL-3, and IL-5
Receptors Reveals a Novel Dimer Configuration
One characteristic feature of the cytokine class I re-
ceptors to which the bc subunit belongs is the cytokine
receptor homology module consisting of two fibronectin
III domains with conserved sequence features (Bazan,
1990; Sato and Miyajima, 1994). The structure of the
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This structural motif is repeated with slight variations
in the ligand complexes of the prolactin (Somers et al.,
1994), erythropoietin (Livnah et al., 1996; Syed et al.,
1998), and IL-4 a receptors (Hage et al., 1999) and withSummary
the gp130 cytokine receptor homology region (Bravo et
al., 1998). Ligand-induced dimerization is believed toThe receptor systems for the hemopoietic cytokines
GM-CSF, IL-3, and IL-5 consist of ligand-specific a result in close association of the cytoplasmic regions
of the receptors, resulting in initiation of signaling viareceptor subunits that play an essential role in the
activation of the shared bc subunit, the major signaling the JAK/STAT pathway (Ihle et al., 1997). In the case of
the erythropoietin receptor, recent evidence suggestsentity. Here, we report the structure of the complete
bc extracellular domain. It has a structure unlike any that it exists on the cell surface as a preformed dimer
that is converted to the activated state by ligand bindingclass I cytokine receptor described thus far, forming
a stable interlocking dimer in the absence of ligand in (Livnah et al., 1999; Remy et al., 1999). A different type of
ligand/receptor association is evident with the cytokinewhich the G strand of domain 1 hydrogen bonds into
the corresponding b sheet of domain 3 of the dimer- receptor homology region of the G-CSF receptor which
forms a 2:2 complex with ligand (Aritomi et al., 1999).related molecule. The G strand of domain 3 similarly
partners with the dimer-related domain 1. The struc- The larger, more complex extracellular domains like
those of the bc, gp130, and G-CSF receptors provideture provides new insights into receptor activation by
the respective a receptor:ligand complexes. difficulties in terms of both structural determination and
predictive modeling. To date, researchers have simpli-
fied this problem by concentrating on their cytokineIntroduction
receptor homology modules. However, important struc-
tural features can be missed by this approach. Here, weGM-CSF, IL-3, and IL-5 are related cytokines involved
in the regulation of hematopoiesis and inflammation. report the structure of the complete extracellular domain
of the bc subunit at 3.0 A˚ resolution, which reveals aGM-CSF and IL-3 are both broadly acting growth regula-
tors with activities on a number of lineages of myeloid novel interlocking dimer structure and gives new in-
sights into the mechanism of receptor activation.cells whereas IL-5 is much more specific in its action
with a unique role in the regulation of eosinophils. IL-5
plays an obligatory role in the generation of the eosino- Results and Discussion
philia characteristic of helminth infections and allergic
diseases such as asthma (Kopf et al., 1996). IL-5 and Structure Determination
eosinophils appear to be central to the inflammatory The complete extracellular domain of the human bc sub-
mechanisms underlying asthma (Foster et al., 1996; unit was expressed in insect cells using the baculovirus
Mould et al., 1997) and IL-5 is now a recognized drug system and purified by gel filtration and anion exchange
target for asthma. chromatography. To obtain good quality crystals, site-
The receptors for the three cytokines consist of cyto- directed mutagenesis was used to remove an N-glyco-
kine-specific a receptors essential to the activation of sylation site at N328. The preparation of heavy atom
the shared bc receptor subunit that is believed to be derivatives also required extensive mutagenesis to in-
the main signaling entity (Tavernier et al., 1991; Takaki troduce single cysteine residues at different sites in the
et al., 1993). The stoichiometry of the activated receptor protein chain. The structure was determined to a resolu-
complexes and the mechanism of bc activation are un- tion limit of 3.0 A˚. The crystals obtained belong to the
known. No X-ray structures are currently available for space group R3 with a 5 185.7 and c 5 103.3 A˚, and
the complete extracellular domains of any of the a sub- contain two molecules in the asymmetric unit. The struc-
units, the bc subunit, or their ligand complexes. ture was determined by multiple isomorphous replace-
ment with anomalous scattering (MIRAS) using six cys-
teine substitution mutants for the preparation of heavy‡ To whom correspondence should be addressed (e-mail: ian.young@
anu.edu.au). atom derivatives. The heavy atom derivatives from five
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Table 1. Data Collection and Refinement Statistics
Resolution Completeness
Dataset (A˚) Observations Unique ,I/s(I). (%) Rmerge1 Sites PhP2 Rcullis3
native 3.0 281,274 26,568 20.3 99.8 0.061 n/a n/a n/a
(3.11–3.00 2,687 100.0 0.310)
S54C/S368C/S166C 3.4 196,812 35,154 9.3 96.1 0.088 6 1.87 0.67
(3.52–3.40 3,335 90.5 0.312)
S368C 2.9 185,634 58,800 17.3 99.7 0.061 2 1.06 0.83
(3.00–2.90 5,820 99.9 0.286)
S157C 3.3 143,402 38,266 14.2 95.2 0.046 2 0.94 0.85
(3.42–3.30 3,839 94.6 0.139)
S166C 3.4 147,945 34,775 8.3 95.4 0.109 2 1.44 0.76
(3.52–3.40 3,499 94.0 0.379)
S54C 3.2 79,308 40,552 14.1 93.7 0.045 2 0.82 0.88
(3.31–3.20 3,972 92.1 0.123)
K204C 3.4 103,489 34,330 10.0 94.4 0.086 2 0.92 0.87
(3.52–3.40 3,435 93.4 0.248)
Values shown in parentheses are for the highest resolution shell
Refinement
Resolution range 35.0–3.0 A˚
Number of reflections (fmin . 350.0) 18,727 (70.4% complete)
Bulk solvent correction (density level) 0.195 eA˚23
(B-factor) 10.0 A˚2
Rcryst4/Rfree5 0.267/0.304
Number of non-hydrogen atoms 6388
Rms bond length deviation 0.0092 A˚
Rms bond angle deviation 1.6238
Overall B-factor 38.3 A˚2
rms difference in B-factors of bonded mainchain atoms 4.8 A˚2
rms difference in B-factors of bonded sidechain atoms 6.9 A˚2
rms displacement of ncs-related Ca positions 1.41 A˚
Interdomain interfaces
Domains Buried Surface Area6 (A˚2) Loops at interface Elbow angle7 e 8 Twist angle7 t8 Swivel angle7 s8
A1/B4 517 AB,EF/FG,BC 83.5 164.9 95.5
A1/B3 718 ,A8,BC8/BC8 98.2 100.8 2105.0
B3/B2 270 DE/CD,EF 88.8 85.0 212.3
B3/A2 582 EF,AB/BC,FG 70.9 114.5 147.5
GHR9 473 AB,EF/FG,BC 74.3 139.7 128.6
1 Rmerge 5 ouIh 2 ,Ih.u/oIh where ,Ih. is the average intensity over symmetry equivalents.
2 PhP 5 Phasing Power 5 ouFhu/ouuFPHobsu 2 uFPHcalcuu, where F is the structure factor.
3 Rcullis 5 ouuuFPHu 6 uFpuu 2 uFHuu/ouuFPHu 6 uFPuu for centric reflections.
4 Rcryst 5 ouFobs 2 FcalcuoFobs.
5 Rfree 5 Rcryst calculated from a test set of 5% of reflections not used in the refinement.
6 Buried surface area was calculated as half of the difference between the surface area of a two domain complex and the sum of the surface
areas of the individual domains. Calculations were done using the program DSSP (Kabsch and Sander, 1983).
7 Interdomain angles calculated according to the method of Deivanayagam et al. (1999).
8 Indicates helical regions.
9 The B chain of human growth hormone receptor from 3hhr.pdb.
such mutants were used for phasing (Table 1) but that proposed that the bc extracellular domain is composed
of two cytokine receptor homology modules. In agree-from the sixth (T418C) was only used for the determina-
tion of the heavy atom position. The structure was re- ment with this, only domains 1 and 3 have disulfide
bridges. Domains 2 and 4 are classical fibronectin typefined to an Rcryst of 0.267 and Rfree of 0.304 for data
extending to 3.0 A˚ spacing (Table 1). It is a dimer of two III domains consisting of two antiparallel b sheets of
three strands (designated A, B, and E) and four strandsidentical subunits and comprises 408 out of 419 residues
in each chain with glycosylation at N34 and N167. Resi- (G, F, C, and D) respectively packed together via multiple
hydrophobic interactions. Domains 1 and 3 also havedues 259–266 and 417–419 were disordered in the crys-
tal and excluded from structural analysis. fibronectin III topology but strand D is extended and
forms part of both b sheets, as is found in the h-type
topological class of the immunoglobulin fold (Bork etThe bc Subunit Fold
The bc subunit extracellular domain is an intertwined al., 1994). Domain 1 has six cysteines engaged in three
disulfide bridges (C11–C21, C51–C72, and C62–C67).dimer (Figure 1). Each subunit consists of four domains
each with an approximate fibronectin type III topology Domain 3 has four cysteines in two disulfide bridges
(C226–C236 and C271–288). A highly novel feature of(Figure 1), and the two chains are related by an approxi-
mate, local, noncrystallographic 2-fold axis. Bazan (1990) these two domains is that in each case, strand G is
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Figure 1. Structure of bc Receptor Drawn Using RIBBONS (Carson, 1991)
Top and middle left, three orthogonal views of the dimer. Chain A is colored red and chain B is colored yellow. Colored spheres depict the
positions of the Hg atoms in the six heavy atom derivatives: cyan, those associated with the A chain; magenta, their equivalent positions on
the B chain. Magenta sticks show the Trp–Arg zipper side chains. Other sticks show the glycosylation sites color coded according to atom
type: green, carbon; red, oxygen; and blue, nitrogen. Middle right, monomeric protein chain. Bottom, topology diagram showing arrangement
of b strands.
extended away from its own domain and forms the G approximately 90–140 A˚ apart. Based on results with
the erythropoietin receptor (Remy et al., 1999), this sepa-strand of a fibronectin domain in the other protein chain
(Figure 1). Strand G of domain 1 forms strand G of do- ration is too great for activation of receptor-associated
JAK2 kinase to occur. The separation should be suffi-main 3 of the dimer-related molecule and likewise strand
G of domain 3 partners with the dimer-related domain cient to accommodate two a receptor subunits internal
to the bc dimer to participate in receptor activation,1. For each of the Hg derivatives produced from the six
independently engineered cysteine substitution mu- although this is dependent on the structures of the a
receptors which are, at present, unknown.tants, it was possible to calculate the three-dimensional
position of the Hg atom along with the vector relating
the dimer-equivalent position. The sites of the Hg atoms Features of the bc Structure
A sequence alignment of the human bc subunit withare shown in Figure 1 and confirm the novel arrangement
of domains in this structure. other known b subunits is given in Figure 2 and shows
the position of various structural features. The bc sub-The unusual fold in the bc receptor structure gener-
ates a stable intertwined dimer whose two membrane- unit from eosinophil-like cells derived from HL60 used
in the present work has an insertion of six amino acidsproximal domains (domains A4 and B4) are positioned
at z608 to the hypothetical plane of the membrane and in the C-D loop of domain 3 compared to the originally
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Figure 2. Sequence Alignment of the Extracellular Domains of the bc and bIL-3 Receptors
hBc(HL60) human bc from HL60 cells used in this study. hBc(TF1) human bc from TF1 cells. mBc, mouse bc. mbIL-3, mouse IL-3 specific b
receptor. The WSXWS sequence motif and the cysteines forming disulfide bonds are colored blue and yellow, respectively. The position of
the b strands and helical regions predicted using the program YASSPA (Kleywegt and Jones, 1997) are also shown: b strand, green; and
helix, red.
described bc subunit from TF1 cells (Gorman et al., quality of the crystals. A crystal contact occurs between
residue Q328 in chain A and a symmetry-related equiva-1990; Hayashida et al., 1990) and is a splicing variant
with normal activity in growth signaling (S. E. G. et al., lent in chain B of the dimer. A recent study has shown
that each of the N-glycosylation sites in the bc subunitsubmitted). This loop is largely absent from the struc-
ture, presumably due to mobility. is required for the formation of a high affinity complex
with GM-CSF (Niu et al., 2000).Although predominantly b sheet, there are a number
of short helical turns in the bc subunit, some of which As is usual with other receptors in this family, there
is good conservation of the fibronectin III topology inare at the domain interfaces (Figures 2 and 5). For exam-
ple, the helical turns at the C-terminal end of the each domain with significant variation in the loops. The
swapped G strands of domains 1 and 3, respectively,
facilitate an approximate right angle turn in the chain at
these points. Short helical turns are also found at the
end of connecting G strands in other receptors such as
the erythropoietin receptor (Livnah et al., 1996; Syed et
al., 1998).
Domain 4 of the bc subunit has a WSXWS motif (resi-
dues W407–S411), which is similar to those in other
class I cytokine receptors such as the growth hormone
and prolactin receptors (de Vos et al., 1992; Somers
et al., 1994) and forms an extended “Trp–Arg zipper”
between the F and G strands in domain 4 (Figure 3). The
equivalent region in domain 2 of the bc structure does
not have a complete WSXWS motif and forms a much
smaller Trp–Arg zipper comprising W158, R187, W205,
and R189.
N-glycosidic attachment of sugar residues occurs at
two positions (N34 and N167). N34 has been built as two
N-acetylglucosamine (NAG) residues plus a mannose.
N167 has two NAG residues, the first of which is fucosy- Figure 3. Structure of Domain 4
lated. A third glycosylation site, N328, was mutated to The positions of the side chains that form the Trp–Arg zipper and
those of the “affinity converting” residues are shown.glutamine to remove glycosylation so as to improve the
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nature of the interfaces between the domains is listed
in Table 1. The interfaces between domains A1 and B4
and between A2 and B3 are similar to those of cytokine
receptors that are activated by homodimerization, such
as the growth hormone receptor (de Vos et al., 1992).
The interface between domains A1 and B3 represents
a larger burying of surface area and involves the interac-
tions of three helices from the B-C loops of both domains
and the N-terminal region of domain A1. The elbow
angles, e, between domains range from 70.98 to 98.28
(Table 1). The propensity for approximate orthogonality
of domains in this class of receptors is maintained in
this structure, albeit in a novel conformation.
Mechanism of Dimer Formation
The swapping of G strands in the bc subunit structure
has features similar to three dimensional domain swap-
ping (Schlunegger et al., 1997), where an element of
secondary structure or a whole domain is swapped with
Figure 4. Cross-linking of the Membrane Form of the bc Receptoran identical protein chain to form an intertwined dimer.
bc503 was expressed in insect cells and the cells lysed, cross-linkedHowever, unlike three-dimensional domain swapping,
with different levels of BS3, and analyzed by Western blotting asno closed monomer form of the bc subunit has been
described in Experimental Procedures. The purified bc extracellular
detected and the swapped G strands are not in the domain dimer was used as a control in a separate experiment under
identical protein environment to that of their parent do- the same conditions.
main. The bc dimer structure is more analogous to the Lane 1, bc extracellular domain (1 mg); lane 2, bc extracellular do-
main plus BS3 (7 mM); lane 3, bc503; and lanes 4, 5, and 6, bc503 plusIL-5 dimer (Milburn et al., 1993) where helix D and strand
BS3 at 1, 2, and 5 mM, respectively.2 appear to have been exchanged as a result of an
ancestral domain swapping event that has subsequently
undergone evolutionary selection, resulting in a short- functional significance (S. E. G. et al., submitted). In
ened hinge loop that precludes the formation of stable addition, we have shown that the dimer form of bIL-3
monomeric species (Milburn et al., 1993). In agreement extracellular domain has the ability to bind IL-3 and to
with this hypothesis, a biologically active monomer form form a ternary complex with the a receptor (unpublished
of IL-5 has been created by extending the hinge loop data). The bIL-3 extracellular domain expressed from COS
using residues from the corresponding loop of the cells also binds IL-3 (Wang et al., 1992) and has a molec-
closely related monomeric cytokine GM-CSF (Dickason ular weight of about 160 kDa by gel filtration, consistent
and Huston, 1996). Inspection of the interactions be- with it being a dimer or oligomer (Ogorichi et al., 1992).
tween the residues forming the G strands and their The bc dimer structure is therefore not a crystallization
neighboring atoms in bc, using inter alia the program artifact.
LIGPLOT (Wallace et al., 1995), did not reveal any inter- The membrane form of the bc receptor is also a dimer.
actions that would preclude the placement of the strand The results of cross-linking studies that show this are
back in its parent domain. However, the F-G loops in given in Figure 4. bc503, which has a truncated cyto-
domains 1 and 3 are very short and contain proline plasmic domain but normal extracellular and transmem-
residues. This may favor extension of the G strands away brane domains, was expressed in insect cells using the
from the parent domains and facilitate participation in baculovirus system and analyzed by Western blotting
G strand swapping. with and without cross-linking. bc503 is a convenient size
to compare with the purified extracellular domain in
terms of cross-linking results. Other studies have shownBiological Relevance of the bc Dimer
The bc subunit extracellular domain was produced in that truncation of the bc cytoplasmic domain does not
affect its ability to be expressed in the membrane or toinsect cells using the baculovirus system that has given
faithful expression of a number of proteins consisting form a normal high affinity complex (Sakamaki et al.,
1992). The purified bc extracellular domain dimer wasof fibronectin domains (Aritomi et al., 1999; Kishore et
al., 1997) and avoids potential refolding artifacts. Full- used as a positive control. The bc extracellular domain
(monomer size 54 kDa) was completely converted to alength human IL-5a and bc receptors expressed using
the baculovirus system have been shown to form a nor- higher molecular weight form by cross-linking with BS3
(Figure 4). The apparent size of the cross-linked formmal high affinity complex by binding studies (Zhang et
al., 1999). Thus, there is no reason to believe that the was 2.7 times that of the monomer rather than double.
We attribute this to the inability of the cross-linked inter-novel bc dimer structure results from the expression
system used. twined dimer to completely denature and maximally bind
SDS, resulting in lower than expected electrophoreticWe have also shown by analytical ultracentrifugation
and native gel electrophoresis that the purified extracel- mobility and higher apparent size. No bands were ob-
tained when the insect cells were infected with an unre-lular domain is greater than 90% dimer with no monomer
detectable. The extracellular domains of the mouse bc lated baculovirus construct (data not shown). bc503
(monomer size 63 kDa) could also be completely con-and bIL-3 subunits also form stable dimers, suggesting
Cell
296
ligand GM-CSF. As a result of the addition of GM-CSF,
the bc dimer formed a complex with the a receptor and
was phosphorylated, indicating that it could participate
normally in receptor activation.
Potential Interactions with Ligands
The bc subunit does not bind GM-CSF, IL-3, or IL-5
detectably on its own. However, in the presence of the
respective a subunits, high affinity complexes are
formed in which the ligand is closely associated with
the bc subunit. The two domains closest to the mem-
brane on either side of the dimer (domains A1–B4 and
B1–A4) adopt the characteristic L-shaped topology seen
in the growth hormone receptor and related two-domain
receptors (Figures 1 and 5). In these receptors, loops in
the elbow region have been shown to participate in
ligand binding (de Vos et al., 1992; Somers et al., 1994;
Livnah et al., 1996; Syed et al., 1998; Hage et al., 1999;
Bravo et al., 1998), particularly the B-C and F-G loops
of the membrane-proximal domain and the E-F loop of
the membrane-distal domain. In the bc structure, the
A-B, C-D, and E-F loops of domain 1 and also the B-C
and F-G loops of domain 4 are potentially accessible
for ligand binding.
Interaction of the bc subunit with ligands could there-
fore occur in an analogous way to the interaction, for
example, between the IL-4 receptor a and IL-4 (HageFigure 5. Two Alternative Models of Ligand Binding to bc Illustrated
Using IL-5 and GM-CSF et al., 1999), although the interactions would be weaker,
Top, IL-5 dimer (magenta and rose) with its ncs dyad coincident with a molecule of ligand potentially binding on each
with that of bc. bc molecule is color-coded according to secondary side of the dimer. It is expected that the conserved
structure: green, b strands; blue, 310 helix; and cyan, a helix. Random glutamate residues (E13, IL-5; E22, IL-3; E21, GM-CSF)
coil is colored according to protein chain: A, red; and B, yellow. would be involved in the interaction with bc based on
Stick models are used for sugar residues. Below left, IL-4Ra:IL-4
previous mutagenesis studies (Barry et al., 1994; Hercuscomplex: cyan, IL-4; green, b strands; and orange, random coil of
et al., 1994; Tavernier et al., 1995). A hypothetical modelIL-4Ra. Below right, bc domains A4–B1 rotated slightly from above
to show interacting loops more clearly and GM-CSF (orange) posi- of ligand binding to the A1/B4 interface region of the bc
tioned similarly to IL-4 in its interaction with IL-4 receptor a. The dimer is shown in Figure 5. The ligand shown in the
first eight residues of random coil of GM-CSF have been omitted model is GM-CSF so as to facilitate comparison with
for clarity. The structures of IL-5, GM-CSF, and the IL-4 receptor the IL-4 receptor a: ligand complex.
a:IL-4 complex are taken from 1hul.pdb, 2gmf.pdb, and 1iar.pdb,
The involvement of the B-C and F-G loops of domain 4respectively.
in ligand binding is supported by previous mutagenesis
studies. Four residues in domain 4 have been identified
(Y347, H349, I350 in the B-C loop and Y403 in the F-Gverted by cross-linking to a higher molecular weight
form after solubilization from insect cells (Figure 4). The loop; numbered according to Figure 2) that appear to
be involved in high affinity complex formation (Lock etapparent size of the cross-linked bc503 was about 2.7
times that of the monomer form analogous to the cross- al., 1994; Woodcock et al., 1994, 1996; Haman et al.,
1999). These residues are shown in Figure 3. Residueslinking results for the purified bc extracellular domain.
These data provide strong support for the concept that in the B-C loop of domain 4 have also been implicated
from mutational studies in the direct binding of IL-3 toall of the bc in the membrane is present as a dimer and
suggest that this is likely to be the functional form. the mouse IL-3 specific b subunit (Wang et al., 1992),
which is highly homologous to the bc receptor.The dimer structure is also plausible in terms of what
is known about receptor activation. It has putative ligand Recently, an NMR structure of domain 4 of the bc
subunit (Mulhern et al., 2000) and an X-ray structure ofbinding sites (Figure 5) that conform to the principles
already established for this receptor family (e.g., growth domain 4 complexed with an antibody (Rossjohn et al.,
2000) have been reported. The relative positions of thehormone receptor) and with the existing mutagenesis
data on affinity converting residues. In addition, the two b strands appear to be in good agreement in the above
two studies and the present work. Of the key residues incysteine residues in domain 1 (C62 and C67) that are
required for activation of bc are part of an exposed domain 4 believed to be involved in high affinity complex
formation, the orientation of I350 is consistent in all threepointed loop that is well positioned for interaction with
the a receptor. studies but there appears to be significant differences
in the sidechain orientations of Y347, H349, and Y403.Further support for the bc dimer being the functional
form of the receptor comes from the work of Muto et The presence of the antibody and absence of the adja-
cent domain may contribute to the differences betweenal. (1996). These authors showed that a dimer form of
bc was detectable in cells prior to the addition of the the present structure and that of the isolated domain
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4–antibody complex. In the present work, the electron
density shows some evidence for two discretely disor-
dered positions of the Y403 side chain. The less favored
position (weaker density) places the side chain pointing
back toward the interface between domains 1 and 4. How-
ever, there are crystal contacts in this region that may
be affecting the disposition of the Y403 side chain. The
positions of the key residues are shown in Figure 3.
The bc structure is also suggestive of an alternative
mode of ligand binding. This is best illustrated with the
IL-5 dimer. It is possible to position IL-5 in two alternative
positions with its dimer axis coincident with the noncrys-
tallographic symmetry dyad of bc. The position with the
greatest surface complementarity would produce the
salt bridges K12 (IL-5) –E239(bc) and E13(IL-5)–R242(bc)
(Figure 5). A number of other interactions in this vicinity
are also predicted, namely: R66(bc)–E66(IL-5), R31(bc)–
T64(IL-5), E243(bc)–R67(IL-5), and D28(bc)–R67(back-
Figure 6. Surface Plots Produced by GRASP (Honig and Nicholls,bone N, IL-5). A small conformational change in either
1995)
the D-E loop of domain 3 or the N-terminal helix of IL-5
Orientations of the molecule are the same as in Figure 1. Color
would be required to achieve the most optimal fit. The coding: green, hydrophobic regions; and blue, polar regions.
D-E loop of domain 3 includes two glycine residues
(G278 and G280) that could facilitate such a movement.
In addition, there is evidence to suggest that the IL-5 main 4 (M345 and I350; M379 and A380; and A323, P324,
dimer exists in two conformers and that there may be and M343); and (3) patches on domain 1 (L6 and L9,
a transition between the two, which would affect the V73 and P75, and V80 and V81). Two other prominent
N-terminal helix upon receptor binding (Verschelde et hydrophobic patches occur on domains 2 and 3 close to
al., 1998). Since previous mutagenesis studies have the “top” (membrane distal side) of the molecule (P135,
been based on the growth hormone receptor structure, V233, P291, P293, and P295, and L132 and P142).
there is no mutagenesis data that relates to this model.
Receptor Activation
The principles governing the activation of shared recep-Potential Interaction with a Receptors
Subsequent to the formation of the high affinity complex, tors like the bc subunit to which the ligands do not
detectably bind in the absence of the ligand-specificit appears that a disulfide bond is formed between the
a and bc subunits, which is necessary for receptor acti- subunits have yet to be established. There is no evidence
that the receptor a:ligand complexes bind strongly tovation. Mutagenesis of either C62 or C67 prevents this
cross-link between a and bc subunits from occurring, bc, so a combination of weak interactions, assisted by
high local receptor concentrations in the membrane,suggesting that the D-E loop in domain 1 that incorpo-
rates C62 and C67 is involved (Stomski et al., 1998). shape complementarity, and restricted diffusion due to
membrane anchoring is likely to be involved in the for-This loop is well defined in domain 1 and projects as a
pointed loop or “disulfide finger” into the interior of the mation of the high affinity complex. It is also possible
that stabilization may be assisted by interactions be-structure, where it is accessible (Figure 1). The mem-
brane proximal side of the loop on either side of the tween the cytoplasmic domains. A feature of the high
affinity complexes of bc is that the off-rate for the liganddisulfide bond forms a band of hydrophobic residues
including P65, P63, and A61. The backbone conforma- is significantly lower than the rate for the a receptors
alone (Haman et al., 1999).tion of these residues is in an extended b conformation.
Internal to the loop M57, P69, and the disulfide bond The structure of the bc subunit is the first complete
extracellular domain structure of one of the more com-maintain a hydrophobic environment. The putative inter-
action between the D-E loop of domain 1 and the a plex members of the class I family of cytokine receptors.
Although long recognized from its sequence to consistreceptor subunit suggests that at least part of the a
receptor will be positioned on the inner side of the dimer of two cytokine receptor homology modules, its struc-
ture has remained an enigma. The intertwined dimerin the high affinity complex.
Studies of receptor subunit interactions in the growth revealed by X-ray crystallography is a novel variation
on the structure of the receptors of this family describedhormone ligand:receptor complex have demonstrated
the importance of hydrophobic interactions (de Vos et to date. The bc subunit dimer would not be activated
in the absence of ligand as, based on studies with theal., 1992). Surface plots of hydrophobicity using the pro-
gram GRASP (Honig and Nicholls, 1995) show a number erythropoietin receptor (Livnah et al., 1999; Remy et al.,
1999), the cytoplasmic domains are too far apart. It isof hydrophobic patches on the molecular surface of bc
(Figure 6). Some of these could be involved in stabilizing expected that each bc molecule in the dimer would
be activated by heterodimerization with the respectivea ternary complex of bc with the respective a receptors
or their associated ligands. These include: (1) the mem- ligand: a receptor complexes. Further mutagenesis of
the bc subunit based on the present structure, and prog-brane proximal side of the D-E loop of domain 1 (A61,
P63, and P65, as described above); (2) patches on do- ress in determination of the structure of the ligand:
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of the bond angles were better than expected for 3 A˚ resolution.receptor complexes will be required to clarify the nature
No solvent molecules were included in the model.of interactions involved in affinity conversion and recep-
tor activation. However, the present work provides a
Cross-linking
new structural paradigm for the cytokine class I receptor Human bc503, which has a deletion from residue 504–897 in the
superfamily and should lead to a better understanding cytoplasmic domain, was expressed in Sf9 cells using the baculovi-
of the activation of this interesting receptor system. rus expression vector pBacPAK8 (Clontech). To create recombinant
baculoviruses, pBacPAK8 carrying the coding sequence for bc503
was transfected into Sf9 cells together with pBacPAK6 (Bsu361
Experimental Procedures
digest) according to the manufacturer’s instructions. The recombi-
nant virus was used to infect Sf9 cells in flasks and the cells incu-
Mutagenesis and Crystallization
bated for 48 hr in supplemented Graces insect medium (Gibco). The
The bc subunit extracellular domain was expressed in insect cells
cells from 15 ml of culture were harvested by centrifugation, washed
using the baculovirus system and purified by gel filtration and anion
once in phosphate buffered saline (PBS), resuspended in 150 ml of
exchange chromatography. Full details of the preparation of bc and
lysis buffer (20 mM sodium phosphate buffer [pH 7.5], 150 mM NaCl,
its characterization as a dimer by analytical ultracentrifugation will
1 mM EDTA, 1% Nonidet NP-40, 100 mM Na3VO4, 20 ml proteasebe published elsewhere (S. E. G., submitted). Details of crystalliza-
inhibitor cocktail [Sigma]) and allowed to lyse for 2 hr at 48C with
tion and mutagenesis used to improve crystal quality and to gener-
occasional mixing. The lysate was centrifuged at 15000 3 g for 15
ate heavy atom derivatives will be published separately (unpublished
min and the supernatant divided into four 30 ml samples. Different
data).
levels of BS3 cross-linker (Pierce) were added and the samples
adjusted to a final volume of 60 ml with PBS. After reaction for 2.5
hr at room temperature, the samples were diluted to 180 ml withDiffraction Data
PBS and concentrated to 40 ml using Ultrafree–MC Microcon (10For cryogenic data collection, crystals were soaked in a cryobuffer
kDa cut-off, Amicon). The samples were then boiled with an equalcontaining 9% PEG MME 5000 and 20% MPD in phosphate buffer
amount of SDS sample buffer and 14 ml samples analyzed by SDS-(pH 6.5). Heavy-atom derivatives were prepared by soaking crystals
PAGE followed by Western blotting onto PVDF membranes (Novex)of proteins mutated to generate reactive cysteine residues in a 10%
according to the manufacturer’s instructions. The primary antibody,saturated solution of dimercury acetate dissolved in cryobuffer. One
S-16 (Santa Cruz Biotechnology) was a mouse monoclonal pro-crystal contained protein with three such mutations. Data were col-
duced against full-length human bc and was used at a dilution oflected at a wavelength of 1.0085 A˚ at the FIP beamline of the Euro-
1:200. The secondary antibody was anti-mouse IgG-HRP (Santapean Synchrotron Radiation Facility. This wavelength was chosen
Cruz Biotechnology) and was used at a dilution of 1:2000. The blotsto maximize the anomalous scattering signal, f† , from the Hg atoms.
were developed using Supersignal chemiluminescent substrateThe heavy atom positions for six heavy atom derivatives prepared
(Pierce).from cysteine substitution mutants were readily located using Pat-
tersons and Difference Fouriers. As there were two protein chains
in the asymmetric unit, the resulting heavy atom positions enabled Acknowledgments
the identification not only of the position of known residues, but
also the vector between equivalent dimer-related positions. Data were We gladly acknowledge the help and friendly advice of Michel Roth
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